SHARPIN is an endogenous inhibitor of β1-integrin activation

Juha K. Rantala; Jeroen Pouwels; Teijo Pellinen; Stefan Veltel; Petra Laasola; Elina Mattila; Christopher S. Potter; Ted Duffy; John P. Sundberg; Olli Kallioniemi; Janet A. Askari; Martin J. Humphries; Maddy Parsons; Marko Salmi; Johanna Ivaska

doi:10.1038/ncb2340

SHARPIN is an endogenous inhibitor of β1-integrin activation

Juha K. Rantala, Jeroen Pouwels, Teijo Pellinen, Stefan Veltel, Petra Laasola, Elina Mattila, Christopher S. Potter, Ted Duffy, John P. Sundberg, Olli Kallioniemi, Janet A. Askari, Martin J. Humphries, Maddy Parsons, Marko Salmi, Johanna Ivaska^*

^*Corresponding author for this work

VTT Technical Research Centre of Finland

Research output: Contribution to journal › Article › Scientific › peer-review

173 Citations (Scopus)

Abstract

Regulated activation of integrins is critical for cell adhesion, motility and tissue homeostasis. Talin and kindlins activate β1-integrins, but the counteracting inhibiting mechanisms are poorly defined. We identified SHARPIN as an important inactivator of β1-integrins in an RNAi screen. SHARPIN inhibited β1-integrin functions in human cancer cells and primary leukocytes. Fibroblasts, leukocytes and keratinocytes from SHARPIN-deficient mice exhibited increased β1-integrin activity, which was fully rescued by re-expression of SHARPIN. We found that SHARPIN directly binds to a conserved cytoplasmic region of integrin α-subunits and inhibits recruitment of talin and kindlin to the integrin. Therefore, SHARPIN inhibits the critical switching of β1-integrins from inactive to active conformations.

Original language	English
Pages (from-to)	1315-1324
Journal	Nature Cell Biology
Volume	13
DOIs	https://doi.org/10.1038/ncb2340
Publication status	Published - 2011
MoE publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/ncb2340

Cite this

@article{2b8972db268c4716b5dfb8035450ed39,

title = "SHARPIN is an endogenous inhibitor of β1-integrin activation",

abstract = "Regulated activation of integrins is critical for cell adhesion, motility and tissue homeostasis. Talin and kindlins activate β1-integrins, but the counteracting inhibiting mechanisms are poorly defined. We identified SHARPIN as an important inactivator of β1-integrins in an RNAi screen. SHARPIN inhibited β1-integrin functions in human cancer cells and primary leukocytes. Fibroblasts, leukocytes and keratinocytes from SHARPIN-deficient mice exhibited increased β1-integrin activity, which was fully rescued by re-expression of SHARPIN. We found that SHARPIN directly binds to a conserved cytoplasmic region of integrin α-subunits and inhibits recruitment of talin and kindlin to the integrin. Therefore, SHARPIN inhibits the critical switching of β1-integrins from inactive to active conformations.",

author = "Rantala, \{Juha K.\} and Jeroen Pouwels and Teijo Pellinen and Stefan Veltel and Petra Laasola and Elina Mattila and Potter, \{Christopher S.\} and Ted Duffy and Sundberg, \{John P.\} and Olli Kallioniemi and Askari, \{Janet A.\} and Humphries, \{Martin J.\} and Maddy Parsons and Marko Salmi and Johanna Ivaska",

year = "2011",

doi = "10.1038/ncb2340",

language = "English",

volume = "13",

pages = "1315--1324",

journal = "Nature Cell Biology",

issn = "1465-7392",

publisher = "Springer Nature",

}

TY - JOUR

T1 - SHARPIN is an endogenous inhibitor of β1-integrin activation

AU - Rantala, Juha K.

AU - Pouwels, Jeroen

AU - Pellinen, Teijo

AU - Veltel, Stefan

AU - Laasola, Petra

AU - Mattila, Elina

AU - Potter, Christopher S.

AU - Duffy, Ted

AU - Sundberg, John P.

AU - Kallioniemi, Olli

AU - Askari, Janet A.

AU - Humphries, Martin J.

AU - Parsons, Maddy

AU - Salmi, Marko

AU - Ivaska, Johanna

PY - 2011

Y1 - 2011

N2 - Regulated activation of integrins is critical for cell adhesion, motility and tissue homeostasis. Talin and kindlins activate β1-integrins, but the counteracting inhibiting mechanisms are poorly defined. We identified SHARPIN as an important inactivator of β1-integrins in an RNAi screen. SHARPIN inhibited β1-integrin functions in human cancer cells and primary leukocytes. Fibroblasts, leukocytes and keratinocytes from SHARPIN-deficient mice exhibited increased β1-integrin activity, which was fully rescued by re-expression of SHARPIN. We found that SHARPIN directly binds to a conserved cytoplasmic region of integrin α-subunits and inhibits recruitment of talin and kindlin to the integrin. Therefore, SHARPIN inhibits the critical switching of β1-integrins from inactive to active conformations.

AB - Regulated activation of integrins is critical for cell adhesion, motility and tissue homeostasis. Talin and kindlins activate β1-integrins, but the counteracting inhibiting mechanisms are poorly defined. We identified SHARPIN as an important inactivator of β1-integrins in an RNAi screen. SHARPIN inhibited β1-integrin functions in human cancer cells and primary leukocytes. Fibroblasts, leukocytes and keratinocytes from SHARPIN-deficient mice exhibited increased β1-integrin activity, which was fully rescued by re-expression of SHARPIN. We found that SHARPIN directly binds to a conserved cytoplasmic region of integrin α-subunits and inhibits recruitment of talin and kindlin to the integrin. Therefore, SHARPIN inhibits the critical switching of β1-integrins from inactive to active conformations.

U2 - 10.1038/ncb2340

DO - 10.1038/ncb2340

M3 - Article

SN - 1465-7392

VL - 13

SP - 1315

EP - 1324

JO - Nature Cell Biology

JF - Nature Cell Biology

ER -

SHARPIN is an endogenous inhibitor of β1-integrin activation

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this